Where are HealthTech's soft landing M&A deals in today's market?
Lloyd Price
FEBRUARY 18, 2024
Market Dynamics: Lower valuations: Compared to the heady days of 2021, HealthTech valuations have cooled down, making "soft landing" deals more attractive for both acquirers and targets. Pharmaceutical and Life Sciences Companies: These companies are looking for HealthTech solutions to: Enhance clinical trials and drug development processes.
Let's personalize your content